Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume $2.32 -0.08 (-3.33%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Lixte Biotechnology Short Interest DataCurrent Short Interest12,000 sharesPrevious Short Interest16,200 sharesChange Vs. Previous Month-25.93%Dollar Volume Sold Short$28,920.00Short Interest Ratio0.3 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares2,250,000 sharesFloat Size1,800,000 sharesShort Percent of Float0.67%Today's Trading Volume9,068 sharesAverage Trading Volume264,795 sharesToday's Volume Vs. Average3% Short Selling Lixte Biotechnology ? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Ad Crypto 101 MediaBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.Click here to get The Crypto Bull Run Millionaire Blueprint now. Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202412,000 shares $28,920.00 -25.9%0.7%0.3 $2.41 6/30/202416,200 shares $38,394.00 -12.9%0.9%0.4 $2.37 6/15/202418,600 shares $45,570.00 +53.7%1.0%0 $2.45 5/31/202412,100 shares $28,291.01 -24.8%0.7%0 $2.34 5/15/202416,100 shares $36,869.00 -31.8%0.9%0 $2.29 4/30/202423,600 shares $68,204.00 -71.5%1.3%0 $2.89 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38 3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72 1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07 1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90 10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12 8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56 4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63 3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68 2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79 1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57 12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! 11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71 8/31/202264,500 shares $50,310.00 -30.0%0.9%0.5 $0.78 8/15/202292,100 shares $74,582.58 +435.5%1.3%0.6 $0.81 7/31/202217,200 shares $12,934.40 -27.4%0.2%0.1 $0.75 7/15/202223,700 shares $19,434.00 +0.9%0.3%0 $0.82 6/30/202223,500 shares $17,496.93 -20.3%0.3%0 $0.74 6/15/202229,500 shares $21,537.95 -38.3%0.4%0 $0.73 5/31/202247,800 shares $35,873.90 -12.3%0.7%0 $0.75 5/15/202254,500 shares $51,824.05 -59.9%0.8%0 $0.95 4/30/2022136,000 shares $160,480.00 -92.4%2.7%0 $1.18 4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57 3/31/202216,800 shares $20,664.00 +8.4%0.4%0.1 $1.23 3/15/202215,500 shares $17,050.00 -59.2%0.3%0 $1.10 2/28/202238,000 shares $53,960.00 -9.5%0.7%0 $1.42 2/15/202242,000 shares $68,460.00 -66.0%0.7%0 $1.63 1/31/2022123,600 shares $239,784.00 -62.3%2.2%0.1 $1.94 1/15/2022328,200 shares $643,272.00 +589.5%5.8%0.2 $1.96 12/31/202147,600 shares $56,644.00 +14.2%0.8%0 $1.19 12/15/202141,700 shares $57,963.00 +110.6%0.7%0.8 $1.39 11/30/202119,800 shares $32,274.00 -54.2%0.4%0.4 $1.63 11/15/202143,200 shares $78,192.00 -20.2%0.8%0.9 $1.81 10/29/202154,100 shares $101,708.00 +0.4%1.0%0.7 $1.88 10/15/202153,900 shares $100,793.00 +11.4%1.0%0.1 $1.87 9/30/202148,400 shares $100,672.00 +25.4%0.9%0.1 $2.08 9/15/202138,600 shares $84,148.00 +196.9%0.7%0.1 $2.18 8/31/202113,000 shares $31,980.00 -80.7%0.2%0 $2.46 8/13/202167,400 shares $150,976.00 +2,006.3%1.2%0.2 $2.24 7/30/20213,200 shares $8,800.00 -82.4%0.1%0 $2.75 7/15/202118,200 shares $54,418.00 -37.5%0.3%0.1 $2.99 6/30/202129,100 shares $88,173.00 +193.9%0.5%0.1 $3.03 6/15/20219,900 shares $29,304.00 -66.9%0.2%0 $2.96 5/28/202129,900 shares $81,926.00 +81.2%0.5%0.1 $2.74 5/14/202116,500 shares $42,817.50 -45.7%0.3%0 $2.60 4/30/202130,400 shares $87,856.00 +98.7%0.5%0 $2.89 4/15/202115,300 shares $45,441.00 -62.7%0.3%0 $2.97 3/31/202141,000 shares $132,020.00 +151.5%1.0%0 $3.22 3/15/202116,300 shares $71,231.00 -13.8%0.4%0 $4.37 2/26/202118,900 shares $71,253.00 +575.0%0.5%0 $3.77 2/12/20212,800 shares $10,220.00 +64.7%0.1%0 $3.65 1/29/20211,700 shares $5,346.50 -15.0%0.1%0 $3.15 1/15/20212,000 shares $6,520.00 No Change0.1%0 $3.26 11/15/20208,400 shares $9,492.00 +140.0%N/A2.8 $1.13 10/30/20203,500 shares $3,920.00 +2.9%N/A3.9 $1.12 10/15/20203,400 shares $3,910.00 +17.2%N/A2.1 $1.15 9/30/20202,900 shares $3,393.00 +107.1%N/A1.4 $1.17 9/15/20201,400 shares $1,400.00 +40.0%N/A0.1 $1.00“Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 8/31/20201,000 shares $1,180.00 -9.1%N/A0.3 $1.18 8/14/20201,100 shares $1,298.00 +37.5%N/A0.7 $1.18 7/31/2020800 shares $952.00 -84.0%N/A0.1 $1.19 7/15/20205,000 shares $4,400.00 -2.0%N/A1.4 $0.88 6/30/20205,100 shares $4,590.00 +13.3%N/A3 $0.90 6/15/20204,500 shares $4,050.00 +12.5%N/A3.2 $0.90 5/29/20204,000 shares $3,520.00 No ChangeN/A1 $0.88 5/15/20204,000 shares $3,600.00 -36.5%N/A1.1 $0.90 4/30/20206,300 shares $5,607.00 +26.0%N/A2.4 $0.89 4/15/20205,000 shares $5,000.00 +284.6%N/A0.9 $1.00 3/31/20201,300 shares $1,274.00 +225.0%N/A0.3 $0.98 3/13/2020400 shares $355.60 No ChangeN/A0.2 $0.89 2/28/2020400 shares $368.00 -66.7%N/A0 $0.92 2/14/20201,200 shares $1,068.00 +50.0%N/A0.1 $0.89 1/31/2020800 shares $599.92 No ChangeN/A0.2 $0.75 1/15/2020800 shares $551.20 +100.0%N/A0.3 $0.69 12/31/2019400 shares $280.00 -86.7%N/A0 $0.70 LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 12,000 shares of LIXT short. 0.67% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.67% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 12,000 shares, a decrease of 25.9% from the previous total of 16,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,250,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 1,800,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 0.67% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lixte Biotechnology: Soligenix, Inc. (38.71%), Purple Biotech Ltd (1.60%), JanOne Inc. (1.84%), Cara Therapeutics, Inc. (1.35%), VBI Vaccines Inc. (1.08%), PharmaCyte Biotech, Inc. (0.19%), Unicycive Therapeutics, Inc. (3.08%), Kiora Pharmaceuticals, Inc. (0.67%), Imunon, Inc. (2.99%), Cardio Diagnostics Holdings, Inc. (1.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SNGX Short Interest Data PPBT Short Interest Data JAN Short Interest Data CARA Short Interest Data VBIV Short Interest Data PMCB Short Interest Data UNCY Short Interest Data KPRX Short Interest Data IMNN Short Interest Data CDIO Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.